Date:  09/15/2009

Time:   1:30 to 2:30 pm

Location:   Marriott San Francisco 55 Fourth Street San Francisco, CA, USA 94103

Moderator:   Stephen B. Thau

Description:  

The Impact of the Financial Crisis on Partnering in China

Financial turmoil has impacted partnering activities around the globe, but China seems to have turned the crisis into an opportunity. Taking advantage of the government's stimulus and development programs, and the increasingly strong economy in China, companies that might be struggling elsewhere have been able to continue to secure funding and move their programs forward in China. Hear experts with a variety of financial perspectives discuss why China seems to be on the leading edge of recovery, and what the future holds for the pharma industry around the world.

ChinaBio® Day 2009 will be an all day event, bringing together China-based life science executives with their counterparts from San Francisco and the rest of the world. The event will provide insights into recent developments of the rapidly changing life science industry in China. For more information, please visit http://www.ebdgroup.com/cbd/.

Moderator
Stephen B. Thau, Partner and Co-Chair of the Life Sciences Group, Morrison & Foerster LLP

Panelists
Frank Kung, PhD, MBA, Managing Partner, Vivo Ventures
Y. James Li, Partner, Kleiner Perkins Caufield and Byers
Yuwen Liu, MS, MBA, General Manager, BioBay
Hongbo B. Lu, PhD, MBA, VP and Senior Research Analyst, Piper Jaffray & Co.
William Molloie, Partner, PricewaterhouseCoopers